Back to Trials
NCT02848274Recruiting

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Stanford University

Start Date

10/1/2016

Completion Date

3/1/2027

Summary

The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups for survival in order to improve patient care and outcome.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria * Diagnosis of advanced stage MF or SS (Stages IIB - IVB) within 6 months of presentation to the participating center * Patients that are expected to have care administered at the participating center or jointly with referring physician(s) where follow-up data would be available Exclusion Criteria * Patients diagnosed with early stage MF/SS (Stages IA-IIA) before progressing to advanced stage * Patients diagnosed with advanced MF/SS more than 6 months prior to initial presentation to the participating center * Exclude one-time consultation type of new patients.

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Mycosis FungoidesNon-Hodgkin's Lymphoma

Locations

City of Hope

Duarte, California 91010

United States

Stanford University, School of Medicine

Palo Alto, California 94305

United States

University of Iowa

Iowa City, Iowa 52242

United States

Hackensack University Medical Center

Hackensack, New Jersey 07601

United States

University of Pittsburg

Pittsburgh, Pennsylvania 15260

United States

University of Texas Southwestern

Dallas, Texas 75390

United States

University of Utah Hospital

Salt Lake City, Utah 84132

United States

Hospital Italiano de Buenos Aires

Buenos Aires,

Argentina

Peter MacCallum Cancer Center,

Melbourne,

Australia

University of Sao Paulo Medical School

São Paulo,

Brazil

Peking University First Hospital

Beijing,

China

The University of Tokyo

Tokyo,

Japan

University Hospitals Birmingham

Birmingham,

United Kingdom